AKLI
Price:
$0.4331
Market Cap:
$34.10M
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-06-30
Stock Exchange
NASDAQ
Ticker
AKLI
According to Akili, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.71. This represents a change of -27.85% compared to the average of -0.98 of the last 4 quarters.
The mean historical PE Ratio of Akili, Inc. over the last ten years is -15.76. The current -0.71 PE Ratio has changed 350.48% with respect to the historical average. Over the past ten years (40 quarters), AKLI's PE Ratio was at its highest in in the September 2022 quarter at 0.33. The PE Ratio was at its lowest in in the June 2021 quarter at -97211.54.
Average
-15.76
Median
-5.12
Minimum
-38.15
Maximum
-0.64
Discovering the peaks and valleys of Akili, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.64
Minimum Annual Increase = -84.76%
Minimum Annual PE Ratio = -38.15
Year | PE Ratio | Change |
---|---|---|
2023 | -0.64 | -84.76% |
2022 | -4.20 | -17.96% |
2021 | -5.12 | -83.31% |
2020 | -30.69 | -19.54% |
The current PE Ratio of Akili, Inc. (AKLI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.32
5-year avg
-15.76
10-year avg
-15.76
Akili, Inc.’s PE Ratio is less than EUDA Health Holdings Limited (0), greater than FOXO Technologies Inc. (-7.53), less than Aclarion, Inc. (-0.14), less than Augmedix, Inc. (-0.26), greater than ETAO International Co., Ltd. (-5.17), greater than Computer Programs and Systems, Inc. (-6.47), greater than National Research Corporation (-163.59), less than Forian Inc. (17.71), less than HealthEquity, Inc. (37.19), less than Health Catalyst, Inc. (62.86), greater than Streamline Health Solutions, Inc. (-5.00), greater than HealthStream, Inc. (-1.65), less than NextGen Healthcare, Inc. (48.26), greater than null (-258.41),
Company | PE Ratio | Market cap |
---|---|---|
0 | $104.68M | |
-7.53 | $2.04M | |
-0.14 | $1.66M | |
-0.26 | $114.18M | |
-5.17 | $9.78M | |
-6.47 | $133.71M | |
-163.59 | $518.25M | |
17.71 | $73.11M | |
37.19 | $6.66B | |
62.86 | $440.83M | |
-5.00 | $33.31M | |
-1.65 | $861.77M | |
48.26 | $1.61B | |
-258.41 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akili, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akili, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Akili, Inc.'s PE Ratio?
How is the PE Ratio calculated for Akili, Inc. (AKLI)?
What is the highest PE Ratio for Akili, Inc. (AKLI)?
What is the 3-year average PE Ratio for Akili, Inc. (AKLI)?
What is the 5-year average PE Ratio for Akili, Inc. (AKLI)?
How does the current PE Ratio for Akili, Inc. (AKLI) compare to its historical average?